Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Prevalence and Long Term Effects of Frailty in Elderly Intensive Care Patients
Authors not listed
University Hospital of North Norway · 2022
Abstract
The primary aim is to study change of critical frailty scale (CFS) and health related quality of life (EQ-5D-5L) in a long-term follow-up of ICU survivors. We aim to identify important ICU related predictors for change in CFS and EQ-5D-5L in long term follow up (1 yr).
Secondary aim is to investigate how CFS pre-admission is related to intrahospital treatment intensity level, severity score and mortality.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-10-31 MST
Cite this
APA
Anonymous. (2022). Prevalence and Long Term Effects of Frailty in Elderly Intensive Care Patients. <em>University Hospital of North Norway</em>. https://clinicaltrials.gov/study/NCT06012942
Vancouver
Anonymous. Prevalence and Long Term Effects of Frailty in Elderly Intensive Care Patients. University Hospital of North Norway. 2022.
BibTeX
@misc{anon2022Preval,
title = {Prevalence and Long Term Effects of Frailty in Elderly Intensive Care Patients},
author = {Anonymous},
journal = {University Hospital of North Norway},
year = {2022},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Istanbul University - Cerrahpasa 2026
Open access · US-GOV
Prognostic Value of CALLY Index, Frailty and SOFA-2 Score for Mortality in Geriatric Intensive Care Patients: A Prospective Cohort Study
Intensive Care Medicine 2014
Preprint · OA
Prevalence and impact of frailty on mortality in elderly ICU patients: a prospective, multicenter, observational study
Oxidative Medicine and Cellular Longevity 2018
Open access · CC-BY
Long‐Term Resveratrol Supplementation as a Secondary Prophylaxis for Stroke
University of Texas at Austin 2026
Open access · US-GOV
Intra-Cellular Therapies, Inc. / "A Randomized, Double-blind, Placebo-controlled, Single Site Study to Evaluate the Efficacy of Lumateperone for the Treatment of Major Depressive Disorder (MDD) and Early Life Trauma in Adult Patients Aged 21 to 70 Years
Selcuk University 2022
Open access · US-GOV
Determining the Prevalence of Frailty in COVID-19 Patients Admitted to the Intensive Care Unit and Evaluating Its Relationship With Mortality.
Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer 2026
Open access · US-GOV